These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28916900)

  • 21. Successful management with fosfomycin + ceftazidime of an infection caused by multiple highly-related subtypes of multidrug-resistant and extensively drug-resistant KPC-producing Serratia marcescens.
    Rodríguez C; Brengi S; Cáceres MA; Mochi S; Viñas MR; Rizza CA; Merletti G; Bru E; Assa JD; Raya RR; Centrón D
    Int J Antimicrob Agents; 2018 Nov; 52(5):737-739. PubMed ID: 30092272
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae.
    Rogers BA; Sidjabat HE; Silvey A; Anderson TL; Perera S; Li J; Paterson DL
    Microb Drug Resist; 2013 Apr; 19(2):100-3. PubMed ID: 23330550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Characterization and Epidemiologic Study of NDM-1-Producing Extensively Drug-Resistant Escherichia coli.
    Du J; Li B; Cao J; Wu Q; Chen H; Hou Y; Zhang E; Zhou T
    Microb Drug Resist; 2017 Apr; 23(3):272-279. PubMed ID: 27383695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.
    Williamson DA; Sidjabat HE; Freeman JT; Roberts SA; Silvey A; Woodhouse R; Mowat E; Dyet K; Paterson DL; Blackmore T; Burns A; Heffernan H
    Int J Antimicrob Agents; 2012 Jun; 39(6):529-33. PubMed ID: 22526013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-β-lactamase-producing Enterobacteriaceae.
    Hagiya H; Sugawara Y; Tsutsumi Y; Akeda Y; Yamamoto N; Sakamoto N; Shanmugakani RK; Abe R; Takeuchi D; Nishi I; Ishii Y; Hamada S; Tomono K
    Int J Antimicrob Agents; 2020 Mar; 55(3):105905. PubMed ID: 31991221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further Modification of the Modified Hodge Test for Detecting Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae.
    Kim HK; Park JS; Sung H; Kim MN
    Ann Lab Med; 2015 May; 35(3):298-305. PubMed ID: 25932437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak caused by Enterobacteriaceae harboring NDM-1 metallo-β-lactamase carried in an IncFII plasmid in a tertiary care hospital in Mexico City.
    Torres-González P; Bobadilla-Del Valle M; Tovar-Calderón E; Leal-Vega F; Hernández-Cruz A; Martínez-Gamboa A; Niembro-Ortega MD; Sifuentes-Osornio J; Ponce-de-León A
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7080-3. PubMed ID: 26282410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.
    Liu C; Qin S; Xu H; Xu L; Zhao D; Liu X; Lang S; Feng X; Liu HM
    PLoS One; 2015; 10(8):e0135044. PubMed ID: 26263489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First report of New Delhi metallo-β-lactamase-1-producing strains in Slovakia.
    Kulkova N; Babalova M; Sokolova J; Krcmery V
    Microb Drug Resist; 2015 Feb; 21(1):117-20. PubMed ID: 25343711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.
    Savard P; Perl TM
    Curr Opin Infect Dis; 2012 Aug; 25(4):371-7. PubMed ID: 22766646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
    Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
    Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.
    Sampaio JL; Gales AC
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):31-37. PubMed ID: 27825605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital sewage water: a reservoir for variants of New Delhi metallo-β-lactamase (NDM)- and extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Parvez S; Khan AU
    Int J Antimicrob Agents; 2018 Jan; 51(1):82-88. PubMed ID: 28887202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.
    Dortet L; Oueslati S; Jeannot K; Tandé D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3823-8. PubMed ID: 25870062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.
    Avolio M; Vignaroli C; Crapis M; Camporese A
    Future Microbiol; 2017 Oct; 12():1119-1122. PubMed ID: 28876082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
    Falagas ME; Karageorgopoulos DE; Nordmann P
    Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.